Mechanism for Chemokine Receptor Fusogenic Activity
趋化因子受体融合活性机制
基本信息
- 批准号:6860152
- 负责人:
- 金额:$ 32.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-05-01 至 2008-02-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The magnitude of the AIDS epidemic has fueled research on the mechanisms involved in HIV-1 infection and pathogenesis. Discovery of the role of (chemokine) coreceptors in viral entry and the crystal structure on the gp120 subunit of the envelope glycoprotein (env) have opened critical avenues for studying the inception of HIV-1 infection. The V3 loop of gp 120 governs viral tropism through coreceptor usage CCR5 is used by env of commonly transmitted strains and CXCR4 by T-tropic strains that evolve in late phases of infection. After activation by CD4, gp 120 can interact with a coreceptor, thereby triggering membrane fusion and viral entry. The focus of the proposed research is to elucidate the mechanism of the interaction between gp120 and coreceptor, a critical point of attack to block HIV-1 infection. Whereas the N-terminus and hydrophobic core with interhelical loops of CCR5 are each sufficient to confer coreceptor activity to hybrids containing segments of inactive chemokine receptors, only that latter region of CXCR4 appears to be involved in the interaction with gpl20 We have demonstrated that gp120 subunits with V3 crown variant lack the ability to utilize the hydrophobic core and interhelical loops of CCR5 for env-mediated fusion and have impaired binding to the wild type receptor, suggesting that these two structures interact. The central hypothesis underlying the proposed research is that extracellular domains of the receptors transiently bind the V3 loop to induce a conformation that is permissive for further interactions involving the nascent coreceptor structures and conserved regions of gp120. The following specific aims are proposed to test this hypothesis 1) To characterize the role of CCR5 N-terminus and second extracellular loop domains in coreceptor activity, 2) To refine insight into the conformation of the CCR5 and CXCR4 hydrophobic core and interhelical loops involved in the interaction with antagonists of coreceptor activity, including ligands and antagonists, 3) To characterize the consequences of coreceptor signaling on the biology of HIV-1 replication using unique CCR5 and CXCR4 signaling variants generated by functionally coupling these coreceptors to the phermone pathway in yeast. The proposed experiments will combine the power of yeast genetics and molecular dynamic simulations to establish a structural basis that will guide the development of strategies to disrupt the role of frontline coreceptors in HIV-1 infection.
描述(由申请人提供):艾滋病流行的规模推动了对艾滋病毒-1感染和发病机制的研究。趋化因子辅助受体在病毒侵入中的作用以及包膜糖蛋白gp120亚单位上的晶体结构的发现,为研究HIV-1感染的开始开辟了重要的途径。GP 120的V3环通过共受体的使用来控制病毒的嗜性,CCR5被常见传播株的环境使用,CXCR4由在感染后期进化的T嗜性株使用。在被CD4激活后,GP 120可以与辅助受体相互作用,从而触发膜融合和病毒进入。建议的研究重点是阐明gp120和辅助受体之间相互作用的机制,辅助受体是阻断HIV-1感染的关键攻击点。虽然CCR5的N端和带有螺旋间环的疏水核心都足以赋予含有非活性趋化因子受体片段的杂交体协同受体活性,但只有CXCR4的后一个区域似乎参与了与gpl20的相互作用。我们已经证明,带有V3冠状变体的gp120亚单位缺乏利用CCR5的疏水核心和螺旋间环进行包膜介导的融合的能力,并损害了与野生型受体的结合,表明这两种结构相互作用。支持这项研究的中心假设是,受体的胞外域瞬时地结合V3环,以诱导一种构象,该构象允许涉及新生的辅受体结构和gp120的保守区的进一步相互作用。为了验证这一假说,提出了以下具体目标:1)鉴定CCR5 N末端和第二细胞外环域在辅受体活性中的作用;2)深入了解CCR5和CXCR4疏水核心和螺旋间环的构象;3)通过在酵母中将这些辅受体与信息素途径进行功能性偶联而产生的独特的CCR5和CXCR4信号变体,来表征辅受体信号对HIV-1复制生物学的影响。拟议的实验将结合酵母遗传学和分子动力学模拟的力量,以建立一个结构基础,指导制定策略来破坏前线辅助受体在HIV-1感染中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen Peiper其他文献
Stephen Peiper的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen Peiper', 18)}}的其他基金
Mechanism for Chemokine Receptor Fusogenic Activity
趋化因子受体融合活性机制
- 批准号:
7013663 - 财政年份:1997
- 资助金额:
$ 32.08万 - 项目类别:
MOLECULAR BASIS OF CHEMOKINE RECEPTOR FUSOGENIC ACTIVITY
趋化因子受体融合活性的分子基础
- 批准号:
2005875 - 财政年份:1997
- 资助金额:
$ 32.08万 - 项目类别:
Mechanism for Chemokine Receptor Fusogenic Activity
趋化因子受体融合活性机制
- 批准号:
7190487 - 财政年份:1997
- 资助金额:
$ 32.08万 - 项目类别:
MOLECULAR BASIS OF CHEMOKINE RECEPTOR FUSOGENIC ACTIVITY
趋化因子受体融合活性的分子基础
- 批准号:
2672993 - 财政年份:1997
- 资助金额:
$ 32.08万 - 项目类别:
MOLECULAR BASIS OF CHEMOKINE RECEPTOR FUSOGENIC ACTIVITY
趋化因子受体融合活性的分子基础
- 批准号:
2887446 - 财政年份:1997
- 资助金额:
$ 32.08万 - 项目类别:
MOLECULAR BASIS OF CHEMOKINE RECEPTOR FUSOGENIC ACTIVITY
趋化因子受体融合活性的分子基础
- 批准号:
6373637 - 财政年份:1997
- 资助金额:
$ 32.08万 - 项目类别:
MOLECULAR BASIS OF CHEMOKINE RECEPTOR FUSOGENIC ACTIVITY
趋化因子受体融合活性的分子基础
- 批准号:
6170439 - 财政年份:1997
- 资助金额:
$ 32.08万 - 项目类别:
Mechanism for Chemokine Receptor Fusogenic Activity
趋化因子受体融合活性机制
- 批准号:
6701795 - 财政年份:1997
- 资助金额:
$ 32.08万 - 项目类别:
Mechanism for Chemokine Receptor Fusogenic Activity
趋化因子受体融合活性机制
- 批准号:
6656750 - 财政年份:1997
- 资助金额:
$ 32.08万 - 项目类别:
MOLECULAR BASIS OF HEMATOPOIETIC GROWTH FACTOR SIGNALING
造血生长因子信号转导的分子基础
- 批准号:
3246752 - 财政年份:1991
- 资助金额:
$ 32.08万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 32.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 32.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 32.08万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 32.08万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 32.08万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 32.08万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 32.08万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 32.08万 - 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 32.08万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 32.08万 - 项目类别:
Studentship